In patients with axial spondyloarthritis (axSpA), pain, functional and structural impairments, reduced mobility and potential deformity of the axial skeleton are the most prominent health concerns. Limitations in physical function and spinal mobility are caused by both inflammation and structural damage, and therefore restrictions to physical function must be monitored throughout a patient’s life. Consequently, the assessment of physical function is recommended as a key domain in the Assessment of Spondyloarthritis International Society–OMERACT Core Outcome Set. However, in comparison with disease activity, physical function seems to be a relatively neglected target of intervention in patients with axSpA, even though physical function is a major contributor to costs and disability in this disease. This Review aims to reacquaint rheumatologists with the targets for physical function, physical activity and performance by giving guidance on determinants of physical function and how physical function can be examined in patients with axSpA.
Impairments in physical function are among the most prominent health concerns in patients with axial spondyloarthritis (axSpA); their assessment is a key domain in the ASAS–OMERACT Core Outcome Set.
The WHO International Classification of Functioning, Disability and Health is the most sophisticated classification system to capture the entire spectrum of functioning and health.
Physical function can be assessed using self-report tools for physical function and physical activity, objective measurements of spinal mobility and performance-based tests.
Physical function in patients with axSpA is influenced by inflammation and structural damage, as well as by comorbidities, mental health and various contextual factors.
Although a combination of pharmacological and non-pharmacological therapy is recommended for the management of axSpA, interventions to improve or maintain function is a relatively neglected target for patients with axSpA.
Interventions to improve physical function include strategies to enhance physical activity on a regular basis and physiotherapy interventions, often in combination with pharmacological treatments.
This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Braun, J. & Sieper, J. Ankylosing spondylitis. Lancet 369, 1379–1390 (2007).
Sieper, J. & Poddubnyy, D. Axial spondyloarthritis. Lancet 390, 73–84 (2017).
Kiltz, U. & van der Heijde, D. Health-related quality of life in patients with rheumatoid arthritis and in patients with ankylosing spondylitis. Clin. Exp. Rheumatol. 27, S108–S111 (2009).
Kiltz, U., Kiefer, D. & Boonen, A. (Health-related) quality of life as an outcome in studies of axial spondyloarthritis. Rheumatic Dis. Clin. North. Am. 46, 379–393 (2020).
Boel, A. et al. Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts. Ann. Rheum. Dis. 78, 1545–1549 (2019).
van der Heijde, D. et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann. Rheum. Dis. 76, 978–991 (2017).
Smolen, J. S. et al. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann. Rheum. Dis. 77, 3–17 (2018).
Rudwaleit, M., Listing, J., Brandt, J., Braun, J. & Sieper, J. Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis. Ann. Rheum. Dis. 63, 665–670 (2004).
Ramiro, S. et al. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann. Rheum. Dis. 73, 1455–1461 (2014).
Machado, P. et al. Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis. Ann. Rheum. Dis. 69, 1465–1470 (2010).
Maxwell, L. J. et al. TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev. 4, CD005468 (2015).
Poddubnyy, D. et al. Physical function and spinal mobility remain stable despite radiographic spinal progression in patients with ankylosing spondylitis treated with TNF-α inhibitors for up to 10 years. J. Rheumatol. 43, 2142–2148 (2016).
Fongen, C. et al. Frequency of impaired spinal mobility in patients with chronic back pain compared to patients with early axial spondyloarthritis. J. Rheumatol. 45, 1643–1650 (2018).
Haibel, H. et al. Health care and disease burden in persons with axial spondyloarthritis in Germany [German]. Z. Rheumatol. 78, 865–874 (2019).
Kiltz, U., Ahomaa, E., Bühring, B., Baraliakos, X. & Braun, J. Clinically relevant deficits in simple performance tests of patients with axial spondyloarthritis (axSpA) – only collecting questionnaires is insufficient [abstract]. Arthritis Rheumatol. 71, 1820 (2019).
Ward, M. M. Functional disability predicts total costs in patients with ankylosing spondylitis. Arthritis Rheum. 46, 223–231 (2002).
Boonen, A. et al. Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries. Ann. Rheum. Dis. 62, 732–740 (2003).
Landewe, R., Dougados, M., Mielants, H., van der Tempel, H. & van der Heijde, D. Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine. Ann. Rheum. Dis. 68, 863–867 (2009).
Chui, E. T. F. et al. MRI inflammation of facet and costovertebral joints is associated with restricted spinal mobility and worsened functional status. Rheumatology 59, 2591–2602 (2020).
Bochkova, A. G., Levshakova, A. V., Bunchuk, N. V. & Braun, J. Spinal inflammation lesions as detected by magnetic resonance imaging in patients with early ankylosing spondylitis are more often observed in posterior structures of the spine. Rheumatology 49, 749–755 (2010).
Dias J. M. in Encyclopedia of Quality of Life and Well-Being Research (ed Michalos A. C.) (Springer, 2014).
Montero-Odasso, M. et al. Gait velocity as a single predictor of adverse events in healthy seniors aged 75 years and older. J. Gerontol. A Biol. Sci. Med. Sci. 60, 1304–1309 (2005).
World Health Organization. International classification of functioning disability and health. who.int https://www.who.int/classifications/international-classification-of-functioning-disability-and-health (2021).
Peeters, G., Dobson, A. J., Deeg, D. J. & Brown, W. J. A life-course perspective on physical functioning in women. Bull. World Health Organ. 91, 661–670 (2013).
Rausch Osthoff, A. K. et al. 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann. Rheum. Dis. 77, 1251–1260 (2018).
Fanning, J. et al. Relationships between profiles of physical activity and major mobility disability in the LIFE study. J. Am. Geriatrics Soc. 68, 1476–1483 (2020).
van Weely, S. F. et al. Moving instead of asking? Performance-based tests and BASFI-questionnaire measure different aspects of physical function in ankylosing spondylitis. Arthritis Res. Ther. 14, R52 (2012).
Yuksel Karsli, T. et al. Comparison of physical activity levels among different sub-types of axial spondyloarthritis patients and healthy controls. Mod. Rheumatol. https://doi.org/10.1080/14397595.2021.1891676 (2021).
Boonen, A. et al. Aspects relevant for functioning in patients with ankylosing spondylitis according to the health professionals: a Delphi study with the ICF as reference. Rheumatology 48, 997–1002 (2009).
Boonen, A. et al. ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health. Ann. Rheum. Dis. 69, 102–107 (2010).
Kiltz, U. et al. Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis. Ann. Rheum. Dis. 77, 1311–1317 (2018).
Kiltz, U. et al. Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS. Ann. Rheum. Dis. 74, 830–835 (2015).
van der Heijde, D. et al. Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. J. Rheumatol. 24, 2225–2229 (1997).
Zochling, J., Braun, J. & van der Heijde, D. Assessments in ankylosing spondylitis. Best. Pract. Res. Clin. Rheumatol. 20, 521–537 (2006).
Calin, A. et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J. Rheumatol. 21, 2281–2285 (1994).
Prince, S. A. et al. A comparison of direct versus self-report measures for assessing physical activity in adults: a systematic review. Int. J. Behav. Nutr. Phys. Act. 5, 56 (2008).
van Genderen, S. et al. Physical functioning in patients with ankylosing spondylitis: comparing approaches of experienced ability with self-reported and objectively measured physical activity. J. Clin. Rheumatol. 20, 133–137 (2014).
Perrotta, F. M., Lories, R. & Lubrano, E. To move or not to move: the paradoxical effect of physical exercise in axial spondyloarthritis. RMD Open 7, e001480 (2021).
Doward, L. C. et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann. Rheum. Dis. 62, 20–26 (2003).
Haywood, K. L., Garratt, A. M., Jordan, K., Dziedzic, K. & Dawes, P. T. Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology 41, 1295–1302 (2002).
Doward, L. C. et al. Translation and validation of non-English versions of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire. Health Qual. Life Outcomes 5, 7 (2007).
Duruoz, M. T. et al. Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire. Rheumatol. Int. 33, 2717–2722 (2013).
Kiltz, U., van der Heijde, D., Boonen, A. & Braun, J. The ASAS Health Index (ASAS HI) – a new tool to assess the health status of patients with spondyloarthritis. Clin. Exp. Rheumatol. 32, S105–S108 (2014).
Kiltz, U., Wendling, D. & Braun, J. ASAS Health Index: The “all in one” for spondyloarthritis evaluation? J. Rheumatol. 47, 1457–1460 (2020).
Kiltz, U. et al. Including contextual factors in the development of a self report questionnaire: the case of environmental factors in the ASAS Health Index [abstract]. Ann. Rheum. Dis. 72, A776 (2013).
Akgul, O. et al. Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry. Rheumatol. Int. 40, 1793–1801 (2020).
Haywood, K. L., Garratt, A. M., Dziedzic, K. & Dawes, P. T. Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology 41, 1380–1387 (2002).
Ware, J. E. Jr. & Sherbourne, C. D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30, 473–483 (1992).
Ware, J. E. Jr., Keller, S. D., Hatoum, H. T. & Kong, S. X. The SF-36 Arthritis-Specific Health Index (ASHI): I. Development and cross-validation of scoring algorithms. Med. Care 37, MS40–MS50 (1999).
Boonen, A. et al. Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept. J. Rheumatol. 35, 662–667 (2008).
Davis, J. C. Jr. et al. Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study. Arthritis Rheum. 57, 1050–1057 (2007).
van Poppel, M. N., Chinapaw, M. J., Mokkink, L. B., van Mechelen, W. & Terwee, C. B. Physical activity questionnaires for adults: a systematic review of measurement properties. Sports Med. 40, 565–600 (2010).
Craig, C. L. et al. International physical activity questionnaire: 12-country reliability and validity. Med. Sci. Sports Exerc. 35, 1381–1395 (2003).
Wendel-Vos, G. C., Schuit, A. J., Saris, W. H. & Kromhout, D. Reproducibility and relative validity of the Short Questionnaire to Assess Health-Enhancing Physical Activity. J. Clin. Epidemiol. 56, 1163–1169 (2003).
Ainsworth, B. E. et al. Compendium of physical activities: an update of activity codes and MET intensities. Med. Sci. Sports Exerc. 32, S498–S504 (2000).
Arends, S. et al. Daily physical activity in ankylosing spondylitis: validity and reliability of the IPAQ and SQUASH and the relation with clinical assessments. Arthritis Res. Ther. 15, R99 (2013).
van Genderen, S. et al. Accelerometer quantification of physical activity and activity patterns in patients with ankylosing spondylitis and population controls. J. Rheumatol. 42, 2369–2375 (2015).
Jenkinson, T. R. et al. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J. Rheumatol. 21, 1694–1698 (1994).
van der Heijde, D. et al. Comparison of three methods for calculating the Bath Ankylosing Spondylitis Metrology Index in a randomized placebo-controlled study. Arthritis Care Res. 64, 1919–1922 (2012).
van der Heijde, D. et al. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum. 52, 582–591 (2005).
Marques, M. L. et al. Measuring spinal mobility in early axial spondyloarthritis: does it matter? Rheumatology 58, 1597–1606 (2019).
Ramiro, S. et al. Hierarchy of impairment of spinal mobility measures in ankylosing spondylitis: twelve-year data. Arthritis Care Res. 67, 1571–1577 (2015).
Martin-Ponce, E. et al. Prognostic value of physical function tests: hand grip strength and six-minute walking test in elderly hospitalized patients. Sci. Rep. 4, 7530 (2014).
Studenski, S. et al. Gait speed and survival in older adults. JAMA 305, 50–58 (2011).
Guralnik, J. M. et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J. Gerontol. 49, M85–M94 (1994).
Ohrnberger, J., Fichera, E. & Sutton, M. The relationship between physical and mental health: a mediation analysis. Soc. Sci. Med. 195, 42–49 (2017).
Pavasini, R. et al. Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis. BMC Med. 14, 215 (2016).
Alfaro-Acha, A., Al Snih, S., Raji, M. A., Markides, K. S. & Ottenbacher, K. J. Does 8-foot walk time predict cognitive decline in older Mexicans Americans? J. Am. Geriatr. Soc. 55, 245–251 (2007).
Mahoney, F. I. & Barthel, D. W. Functional evaluation: The Barthel Index. Md. State Med. J. 14, 61–65 (1965).
Lawton, M. P. & Brody, E. M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9, 179–186 (1969).
Ostir, G. V., Markides, K. S., Black, S. A. & Goodwin, J. S. Lower body functioning as a predictor of subsequent disability among older Mexican Americans. J. Gerontol. A. Biol. Sci. Med. Sci. 53, M491–M495 (1998).
Cesari, M. et al. Prognostic value of usual gait speed in well-functioning older people–results from the Health, Aging and Body Composition Study. J. Am. Geriatr. Soc. 53, 1675–1680 (2005).
Laukkanen, P., Heikkinen, E. & Kauppinen, M. Muscle strength and mobility as predictors of survival in 75-84-year-old people. Age Ageing 24, 468–473 (1995).
van Weely, S. F. et al. Objective evaluation of physical functioning after tumor necrosis factor inhibitory therapy in patients with ankylosing spondylitis: a selection of 3 feasible performance-based tests. J. Rheumatol. 42, 623–629 (2015).
van Weely, S. F. et al. What do we miss? ASAS non-responders on anti-TNF therapy show improvement in performance-based physical function. Rheumatology 52, 1884–1889 (2013).
van Bentum, R. E. et al. The Ankylosing Spondylitis Physical Performance Index: reliability and feasibility of an objective test for physical functioning. J. Rheumatol. 47, 1475–1482 (2020).
Fongen, C. et al. Responsiveness and interpretability of 2 measures of physical function in patients with spondyloarthritis. Phys. Ther. 100, 728–738 (2020).
Rausch, A. K. et al. Reliability of an adapted core strength endurance test battery in individuals with axial spondylarthritis. Clin. Rheumatol. 40, 1353–1360 (2020).
Creemers, M. C. et al. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann. Rheum. Dis. 64, 127–129 (2005).
Poddubnyy, D. et al. Functional relevance of radiographic spinal progression in axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort. Rheumatology 57, 703–711 (2018).
Protopopov, M. et al. Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Res. Ther. 19, 240 (2017).
Machado, P. et al. A stratified model for health outcomes in ankylosing spondylitis. Ann. Rheum. Dis. 70, 1758–1764 (2011).
Carvalho, P. D., Ruyssen-Witrand, A., Fonseca, J., Marreiros, A. & Machado, P. M. Determining factors related to impaired spinal and hip mobility in patients with axial spondyloarthritis: longitudinal results from the DESIR cohort. RMD Open 6, e001356 (2020).
Nikiphorou, E. et al. Association of comorbidities in spondyloarthritis with poor function, work disability, and quality of life: results from the Assessment of SpondyloArthritis International Society Comorbidities in Spondyloarthritis Study. Arthritis Care Res. 70, 1257–1262 (2018).
England, B. R., Sayles, H., Mikuls, T. R., Johnson, D. S. & Michaud, K. Validation of the rheumatic disease comorbidity index. Arthritis Care Res. 67, 865–872 (2015).
EuroQol Group. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy 16, 199–208 (1990).
Reilly, M. C., Gooch, K. L., Wong, R. L., Kupper, H. & van der Heijde, D. Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis. Rheumatology 49, 812–819 (2010).
Redeker, I. et al. The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study. Arthritis Res. Ther. 22, 210 (2020).
Maas, F. et al. Obesity is common in axial spondyloarthritis and is associated with poor clinical outcome. J. Rheumatol. 43, 383–387 (2016).
Fernandez-Carballido, C. et al. Impact of comorbidity on physical function in patients with ankylosing spondylitis and psoriatic arthritis attending rheumatology clinics. Results from a cross-sectional study. Arthritis Care Res. 72, 822–828 (2020).
Ward, M. M. Predictors of the progression of functional disability in patients with ankylosing spondylitis. J. Rheumatol. 29, 1420–1425 (2002).
Ward, M. M., Weisman, M. H., Davis, J. C. Jr. & Reveille, J. D. Risk factors for functional limitations in patients with long-standing ankylosing spondylitis. Arthritis Rheum. 53, 710–717 (2005).
Brophy, S. et al. The effect of physical activity and motivation on function in ankylosing spondylitis: a cohort study. Semin. Arthritis Rheum. 42, 619–626 (2013).
Zhang, L., Wu, Y., Liu, S. & Zhu, W. Prevalence of depression in ankylosing spondylitis: a systematic review and meta-analysis. Psychiatry Investig. 16, 565–574 (2019).
Zhao, S. S. et al. Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. Rheumatology 59, iv47–iv57 (2020).
Li, Y., Zhang, S., Zhu, J., Du, X. & Huang, F. Sleep disturbances are associated with increased pain, disease activity, depression, and anxiety in ankylosing spondylitis: a case-control study. Arthritis Res. Ther. 14, R215 (2012).
Meesters, J. J. et al. The risk for depression in patients with ankylosing spondylitis: a population-based cohort study. Arthritis Res. Ther. 16, 418 (2014).
Katz, S. & Akpom, C. A. 12. Index of ADL. Med. Care 14, 116–118 (1976).
Radloff, L. S. The use of the Center for Epidemiologic Studies Depression Scale in adolescents and young adults. J. Youth Adolesc. 20, 149–166 (1991).
World Health Organization. WHO publishes new guidelines to measure health. who.int https://www.who.int/news/item/15-11-2001-who-publishes-new-guidelines-to-measure-health (2001).
Houses of the Oireachtas. Disability Act 2005. oireachtas.ie https://www.oireachtas.ie/en/bills/bill/2004/39/ (2005).
Burgstahler, S. Universal design: process, principles, and applications. Washington.edu (2015).
Niedermann, K., Nast, I., Ciurea, A., Vliet Vlieland, T. & van Bodegom-Vos, L. Barriers and facilitators of vigorous cardiorespiratory training in axial spondyloarthritis: surveys among patients, physiotherapists, rheumatologists. Arthritis Care Res. 71, 839–851 (2019).
Fongen, C., Sveaas, S. H. & Dagfinrud, H. Barriers and facilitators for being physically active in patients with ankylosing spondylitis: a cross-sectional comparative study. Musculoskelet. Care 13, 76–83 (2015).
Curbelo, R. J., Loza, E., de Yebenes, M. J. & Carmona, L. Databases and registers: useful tools for research, no studies. Rheumatol. Int. 34, 447–452 (2014).
Niedermann, K. et al. Effect of cardiovascular training on fitness and perceived disease activity in people with ankylosing spondylitis. Arthritis Care Res. 65, 1844–1852 (2013).
Ding, D. et al. Physical activity guidelines 2020: comprehensive and inclusive recommendations to activate populations. Lancet 396, 1780–1782 (2020).
Haglund, E. et al. Differences in physical activity patterns in patients with spondylarthritis. Arthritis Care Res. 64, 1886–1894 (2012).
Dagfinrud, H., Kvien, T. K. & Hagen, K. B. Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev. 1, CD002822 (2008).
Liang, H. et al. The comparative efficacy of supervised- versus home-based exercise programs in patients with ankylosing spondylitis: a meta-analysis. Medicine 99, e19229 (2020).
Dagfinrud, H. et al. Exercise programs in trials for patients with ankylosing spondylitis: do they really have the potential for effectiveness? Arthritis Care Res. 63, 597–603 (2011).
Regnaux, J. P. et al. Exercise programmes for ankylosing spondylitis. Cochrane Database Syst. Rev. 10, CD011321 (2019).
Pecourneau, V. et al. Effectiveness of exercise programs in ankylosing spondylitis: a meta-analysis of randomized controlled trials. Arch. Phys. Med. Rehabil. 99, 383–389.e1 (2018).
Escalas, C., Dalichampt, M., Dougados, M. & Poiraudeau, S. Evaluation of physiotherapy in a prospective cohort of early axial spondyloarthritis. Data from the DESIR cohort. Joint Bone Spine 83, 185–190 (2016).
Paul, L. et al. Web-based physiotherapy for people with axial spondyloarthritis (WEBPASS) – a study protocol. BMC Musculoskelet. Disord. 17, 360 (2016).
Lubrano, E. et al. Effects of a combination treatment of an intensive rehabilitation program and etanercept in patients with ankylosing spondylitis: a pilot study. J. Rheumatol. 33, 2029–2034 (2006).
Dubey, S. G., Leeder, J. & Gaffney, K. Physical therapy in anti-TNF treated patients with ankylosing spondylitis. Rheumatology 47, 1100–1101 (2008).
Meier, F. M., Muller-Ladner, U. & Lange, U. Efficacy of intensive physiotherapy in combination with low-dose etanercept in active spondyloarthritis: a monocentric pilot study. J. Rheumatol. 41, 1897–1898 (2014).
Lubrano, E. et al. Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: a systematic review. Semin. Arthritis Rheum. 44, 542–550 (2015).
Liang, H. et al. Concurrent intervention with exercises and stabilized tumor necrosis factor inhibitor therapy reduced the disease activity in patients with ankylosing spondylitis: a meta-analysis. Medicine 94, e2254 (2015).
Halvorsen, S. et al. Physical fitness in patients with ankylosing spondylitis: comparison with population controls. Phys. Ther. 92, 298–309 (2012).
Eriksson, J. K., Jacobsson, L., Bengtsson, K. & Askling, J. Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis? Ann. Rheum. Dis. 76, 364–370 (2017).
Haroon, N. N., Paterson, J. M., Li, P., Inman, R. D. & Haroon, N. Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study. Ann. Intern. Med. 163, 409–416 (2015).
Verhoeven, F. et al. Aerobic exercise for axial spondyloarthritis – its effects on disease activity and function as compared to standard physiotherapy: a systematic review and meta-analysis. Int. J. Rheum. Dis. 22, 234–241 (2019).
Sveaas, S. H. et al. High-intensity exercise improves fatigue, sleep, and mood in patients with axial spondyloarthritis: secondary analysis of a randomized controlled trial. Phys. Ther. 100, 1323–1332 (2020).
Sveaas, S. H. et al. High intensity exercise for 3 months reduces disease activity in axial spondyloarthritis (axSpA): a multicentre randomised trial of 100 patients. Br. J. Sports Med. 54, 292–297 (2020).
Bilberg, A., Sveaas, S. H., Dagfinrud, H. & Mannerkorpi, K. How do patients with axial spondyloarthritis experience high-intensity exercise? ACR Open Rheumatol. 2, 207–213 (2020).
Sveaas, S. H. et al. Longterm effect on leisure time physical activity level in individuals with axial spondyloarthritis: secondary analysis of a randomized controlled trial. J. Rheumatol. 47, 1189–1197 (2020).
Buijze, G. A. et al. An add-on training program involving breathing exercises, cold exposure, and meditation attenuates inflammation and disease activity in axial spondyloarthritis – a proof of concept trial. PLoS ONE 14, e02257490225749 (2019).
Kiltz, U. et al. Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis. Ann. Rheum. Dis. 79, 193–201 (2020).
Regel, A. et al. Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. RMD Open 3, e000397 (2017).
Zangi, H. A. et al. EULAR recommendations for patient education for people with inflammatory arthritis. Ann. Rheum. Dis. 74, 954–962 (2015).
Agca, R. et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann. Rheum. Dis. 76, 17–28 (2017).
The authors declare no competing interests.
Peer review information
Nature Reviews Rheumatology thanks H. Dagfinrud and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Braun, J., Baraliakos, X. & Kiltz, U. Treat-to-target in axial spondyloarthritis — what about physical function and activity?. Nat Rev Rheumatol 17, 565–576 (2021). https://doi.org/10.1038/s41584-021-00656-5